MedPath

Contrast The Role of Avitene And OK-432 in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

Phase 4
Conditions
Drainage
Postoperative Complications
Interventions
Drug: Sapylin
Behavioral: axillary drainage
Other: reexamine
Registration Number
NCT02158299
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Brief Summary

After Axillary lymphadenectomy for breast cancer there are not few patients showed seroma formation and it can not be ignored.Investigators aimed to study two new methods of application of Microfibrillar Collagen Hemostat Flour and OK-432 to reduce seroma formation and to verify the efficacy and safety of these two applications.Try to prove them as beneficial supplements for axillary lymphadenectomy of breast cancer.

Detailed Description

A prospective,randomized analysis of breast-conserving surgery or mastectomy plus axillary lymphadenectomy for those patients with sentinel node positive using Microfibrillar Collagen Hemostat Flour 、 OK-432 or using nothing in equal probability.Up to 12 months,a total of 180 will be recruited in plan.During the operation and after the axillary lymphadenectomy,according the arms,Investigators put Microfibrillar Collagen Hemostat Flour(avitene)、 OK-432(Sapylin) or nothing into patients axillary wounds。And Investigators will the statistical significance of these three arms that the postoperative drainage magnitude and duration.Also the complications associated with axillary lymphadenectomy will be studied.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
3
Inclusion Criteria
  1. Patients volunteered for the study and signed informed consent;
  2. Preoperative biopsy or intraoperative sentinel lymph node biopsy confirmed axillary lymph node metastasis and need axillary lymphadenectomy
  3. No penicillin allergy
  4. No blood system diseases
  5. No rheumatic heart disease
  6. No history or family history of asthma
  7. No history of axillary surgery
Exclusion Criteria
  1. A history of severe hypertension
  2. A history of diabetes
  3. Undergoing anticoagulant therapy or anticoagulant therapy drug withdrawal less than a year
  4. BMI>30
  5. Can not accept telephone follow-up or can not go to the hospital for subsequent inspection treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Avitene,Drainaging,reexaminereexamine-
Sapylin,Drainaging,reexamineSapylin-
Avitene,Drainaging,reexamineaxillary drainage-
Sapylin,Drainaging,reexaminereexamine-
Drainaging,reexamineaxillary drainage-
Drainaging,reexaminereexamine-
Sapylin,Drainaging,reexamineaxillary drainage-
Avitene,Drainaging,reexamineAvitene-
Primary Outcome Measures
NameTimeMethod
postoperative drainage magnitudeup to 1 year
Secondary Outcome Measures
NameTimeMethod
Duration of the drainageup to 1 year

Trial Locations

Locations (1)

Sun Yat-sen Memorial Hospital of Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath